Diamond Hill Capital Management LLC Investment Advisor Takes $4.72 Million Position in InfuSystem Holdings, Inc. $INFU

Diamond Hill Capital Management LLC Investment Advisor bought a new position in InfuSystem Holdings, Inc. (NYSE:INFUFree Report) during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 489,017 shares of the company’s stock, valued at approximately $4,719,000. Diamond Hill Capital Management LLC Investment Advisor owned about 2.42% of InfuSystem as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of INFU. Cubist Systematic Strategies LLC acquired a new position in InfuSystem in the first quarter valued at approximately $129,000. Jane Street Group LLC acquired a new stake in shares of InfuSystem during the 1st quarter worth approximately $96,000. Acadian Asset Management LLC grew its stake in shares of InfuSystem by 219.1% during the 1st quarter. Acadian Asset Management LLC now owns 39,117 shares of the company’s stock worth $208,000 after purchasing an additional 26,860 shares during the period. American Century Companies Inc. increased its holdings in shares of InfuSystem by 147.4% during the 2nd quarter. American Century Companies Inc. now owns 117,812 shares of the company’s stock valued at $735,000 after purchasing an additional 70,188 shares in the last quarter. Finally, XTX Topco Ltd purchased a new position in shares of InfuSystem during the 2nd quarter valued at approximately $185,000. 71.13% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Separately, B. Riley Financial reissued a “buy” rating and set a $20.00 price target (up from $12.00) on shares of InfuSystem in a report on Wednesday, August 5th. Three analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat, InfuSystem presently has an average rating of “Moderate Buy” and a consensus price target of $16.67.

Read Our Latest Stock Report on InfuSystem

InfuSystem Stock Down 0.9%

Shares of INFU opened at $12.16 on Tuesday. The firm has a market cap of $245.41 million, a P/E ratio of 202.70 and a beta of 1.42. InfuSystem Holdings, Inc. has a 12 month low of $7.29 and a 12 month high of $12.97. The stock’s 50 day moving average is $9.92 and its two-hundred day moving average is $9.42. The company has a current ratio of 1.98, a quick ratio of 1.59 and a debt-to-equity ratio of 0.50.

InfuSystem declared that its board has initiated a stock buyback plan on Tuesday, May 19th that authorizes the company to buyback $20.00 million in outstanding shares. This buyback authorization authorizes the company to purchase up to 10.2% of its shares through open market purchases. Shares buyback plans are usually an indication that the company’s leadership believes its stock is undervalued.

InfuSystem Profile

(Free Report)

InfuSystem Holdings Inc is a medical technology company that specializes in the rental, management and servicing of infusion pumps and associated devices used primarily for outpatient infusion therapy. The company provides a comprehensive suite of services that includes equipment delivery, setup and retrieval, preventive and corrective maintenance, reprocessing and quality assurance. InfuSystem’s offerings are designed to help hospitals, ambulatory surgery centers, oncology clinics and private infusion suites streamline clinical operations and maintain compliance with safety standards.

In addition to pump rental and repair services, InfuSystem has expanded into remote patient monitoring solutions.

Featured Articles

Want to see what other hedge funds are holding INFU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for InfuSystem Holdings, Inc. (NYSE:INFUFree Report).

Institutional Ownership by Quarter for InfuSystem (NYSE:INFU)

Receive News & Ratings for InfuSystem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InfuSystem and related companies with MarketBeat.com's FREE daily email newsletter.